ABT vs. NVDA: A Head-to-Head Stock Comparison

Updated on July 7, 2025

Here’s a clear look at ABT and NVDA, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Overview

NVDA’s market capitalization of 3,887.90 billion USD is significantly greater than ABT’s 233.90 billion USD, highlighting its more substantial market valuation.

NVDA carries a higher beta at 2.12, indicating it’s more sensitive to market moves, while ABT (beta: 0.74) exhibits greater stability.

Symbol	ABT	NVDA
Company Name	Abbott Laboratories	NVIDIA Corporation
Country	US	US
Sector	Healthcare	Technology
Industry	Medical - Devices	Semiconductors
CEO	Robert B. Ford	Jen-Hsun Huang
Price	134.44 USD	159.34 USD
Market Cap	233.90 billion USD	3,887.90 billion USD
Beta	0.74	2.12
Exchange	NYSE	NASDAQ
IPO Date	March 17, 1980	January 22, 1999
ADR	No	No

Historical Performance

This chart compares the performance of ABT and NVDA by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period.

Data is adjusted for dividends and splits.

ABT vs. NVDA: Growth of a $10,000 investment over the past one year.

Profitability

Return on Equity

ABT

30.76%

Medical - Devices Industry

Max: 49.04%
Q3: 9.53%
Median: -7.46%
Q1: -32.83%
Min: -82.64%

In the upper quartile for the Medical - Devices industry, ABT’s Return on Equity of 30.76% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.

NVDA

106.92%

Semiconductors Industry

Max: 41.84%
Q3: 15.81%
Median: 6.31%
Q1: -5.54%
Min: -30.12%

NVDA’s Return on Equity of 106.92% is exceptionally high, placing it well beyond the typical range for the Semiconductors industry. This demonstrates a superior ability to generate profit from shareholder investments, though it could also be inflated by high financial leverage.

ABT vs. NVDA: A comparison of their ROE against their respective Medical - Devices and Semiconductors industry benchmarks.

Return on Invested Capital

ABT

19.13%

Medical - Devices Industry

Max: 21.88%
Q3: 6.63%
Median: -1.11%
Q1: -21.08%
Min: -51.95%

In the upper quartile for the Medical - Devices industry, ABT’s Return on Invested Capital of 19.13% signifies a highly effective use of its capital to generate profits when compared to its peers.

NVDA

75.38%

Semiconductors Industry

Max: 30.91%
Q3: 11.34%
Median: 4.08%
Q1: -2.17%
Min: -19.59%

NVDA’s Return on Invested Capital of 75.38% is exceptionally high, placing it well beyond the typical range for the Semiconductors industry. This demonstrates an outstanding ability to deploy capital efficiently and create significant value.

ABT vs. NVDA: A comparison of their ROIC against their respective Medical - Devices and Semiconductors industry benchmarks.

Net Profit Margin

ABT

31.89%

Medical - Devices Industry

Max: 44.80%
Q3: 9.77%
Median: -5.53%
Q1: -29.37%
Min: -87.68%

A Net Profit Margin of 31.89% places ABT in the upper quartile for the Medical - Devices industry, signifying strong profitability and more effective cost management than most of its peers.

NVDA

51.69%

Semiconductors Industry

Max: 51.69%
Q3: 19.67%
Median: 8.56%
Q1: -5.44%
Min: -38.60%

A Net Profit Margin of 51.69% places NVDA in the upper quartile for the Semiconductors industry, signifying strong profitability and more effective cost management than most of its peers.

ABT vs. NVDA: A comparison of their Net Profit Margin against their respective Medical - Devices and Semiconductors industry benchmarks.

Operating Profit Margin

ABT

16.97%

Medical - Devices Industry

Max: 30.13%
Q3: 13.12%
Median: 3.47%
Q1: -24.42%
Min: -80.56%

An Operating Profit Margin of 16.97% places ABT in the upper quartile for the Medical - Devices industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

NVDA

58.03%

Semiconductors Industry

Max: 58.03%
Q3: 22.12%
Median: 8.40%
Q1: -3.73%
Min: -36.14%

An Operating Profit Margin of 58.03% places NVDA in the upper quartile for the Semiconductors industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

ABT vs. NVDA: A comparison of their Operating Margin against their respective Medical - Devices and Semiconductors industry benchmarks.

Profitability at a Glance

Symbol	ABT	NVDA
Return on Equity (TTM)	30.76%	106.92%
Return on Assets (TTM)	16.58%	61.29%
Return on Invested Capital (TTM)	19.13%	75.38%
Net Profit Margin (TTM)	31.89%	51.69%
Operating Profit Margin (TTM)	16.97%	58.03%
Gross Profit Margin (TTM)	55.89%	70.11%

Financial Strength

Current Ratio

ABT

1.78

Medical - Devices Industry

Max: 12.68
Q3: 6.30
Median: 4.05
Q1: 1.85
Min: 0.01

ABT’s Current Ratio of 1.78 falls into the lower quartile for the Medical - Devices industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.

NVDA

3.39

Semiconductors Industry

Max: 9.10
Q3: 5.23
Median: 3.09
Q1: 2.49
Min: 1.02

NVDA’s Current Ratio of 3.39 aligns with the median group of the Semiconductors industry, indicating that its short-term liquidity is in line with its sector peers.

ABT vs. NVDA: A comparison of their Current Ratio against their respective Medical - Devices and Semiconductors industry benchmarks.

Debt-to-Equity Ratio

ABT

0.27

Medical - Devices Industry

Max: 2.34
Q3: 1.09
Median: 0.37
Q1: 0.08
Min: 0.00

ABT’s Debt-to-Equity Ratio of 0.27 is typical for the Medical - Devices industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

NVDA

0.12

Semiconductors Industry

Max: 0.97
Q3: 0.46
Median: 0.21
Q1: 0.05
Min: 0.00

NVDA’s Debt-to-Equity Ratio of 0.12 is typical for the Semiconductors industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

ABT vs. NVDA: A comparison of their D/E Ratio against their respective Medical - Devices and Semiconductors industry benchmarks.

Interest Coverage Ratio

ABT

15.39

Medical - Devices Industry

Max: 18.18
Q3: 7.53
Median: 0.85
Q1: -9.80
Min: -33.94

ABT’s Interest Coverage Ratio of 15.39 is in the upper quartile for the Medical - Devices industry, signifying a strong and healthy capacity to meet its interest payments from operating profits.

NVDA

350.34

Semiconductors Industry

Max: 36.25
Q3: 29.12
Median: 7.01
Q1: -1.22
Min: -18.18

With an Interest Coverage Ratio of 350.34, NVDA demonstrates a superior capacity to service its debt, placing it well above the typical range for the Semiconductors industry. This stems from either robust earnings or a conservative debt load.

ABT vs. NVDA: A comparison of their Interest Coverage against their respective Medical - Devices and Semiconductors industry benchmarks.

Financial Strength at a Glance

Symbol	ABT	NVDA
Current Ratio (TTM)	1.78	3.39
Quick Ratio (TTM)	1.27	2.96
Debt-to-Equity Ratio (TTM)	0.27	0.12
Debt-to-Asset Ratio (TTM)	0.16	0.08
Net Debt-to-EBITDA Ratio (TTM)	0.60	-0.05
Interest Coverage Ratio (TTM)	15.39	350.34

Growth

The following charts compare key year-over-year (YoY) growth metrics for ABT and NVDA. These metrics are based on the companies’ annual financial reports.

Revenue Growth

ABT vs. NVDA: A comparison of their annual year-over-year Revenue Growth.

Earnings Per Share (EPS) Growth

ABT vs. NVDA: A comparison of their annual year-over-year Earnings Per Share (EPS) Growth.

Free Cash Flow Growth

ABT vs. NVDA: A comparison of their annual year-over-year Free Cash Flow Growth.

Dividend

Dividend Yield

ABT

1.70%

Medical - Devices Industry

Max: 3.57%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

With a Dividend Yield of 1.70%, ABT offers a more attractive income stream than most of its peers in the Medical - Devices industry, signaling a strong commitment to shareholder returns.

NVDA

0.03%

Semiconductors Industry

Max: 6.48%
Q3: 0.93%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

NVDA’s Dividend Yield of 0.03% is consistent with its peers in the Semiconductors industry, providing a dividend return that is standard for its sector.

ABT vs. NVDA: A comparison of their Dividend Yield against their respective Medical - Devices and Semiconductors industry benchmarks.

Dividend Payout Ratio

ABT

28.92%

Medical - Devices Industry

Max: 102.12%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

ABT’s Dividend Payout Ratio of 28.92% is in the upper quartile for the Medical - Devices industry. This indicates a strong commitment to shareholder returns but also suggests that a smaller portion of earnings is retained for reinvestment compared to many peers.

NVDA

1.28%

Semiconductors Industry

Max: 204.29%
Q3: 31.85%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

NVDA’s Dividend Payout Ratio of 1.28% is within the typical range for the Semiconductors industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

ABT vs. NVDA: A comparison of their Payout Ratio against their respective Medical - Devices and Semiconductors industry benchmarks.

Dividend at a Glance

Symbol	ABT	NVDA
Dividend Yield (TTM)	1.70%	0.03%
Dividend Payout Ratio (TTM)	28.92%	1.28%

Valuation

Price-to-Earnings Ratio

ABT

17.40

Medical - Devices Industry

Max: 90.56
Q3: 56.92
Median: 43.19
Q1: 21.79
Min: 5.55

In the lower quartile for the Medical - Devices industry, ABT’s P/E Ratio of 17.40 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.

NVDA

50.73

Semiconductors Industry

Max: 86.15
Q3: 47.38
Median: 27.87
Q1: 18.89
Min: 4.73

A P/E Ratio of 50.73 places NVDA in the upper quartile for the Semiconductors industry. This high valuation relative to peers suggests the market holds elevated expectations for the company’s future growth.

ABT vs. NVDA: A comparison of their P/E Ratio against their respective Medical - Devices and Semiconductors industry benchmarks.

Forward P/E to Growth Ratio

ABT

1.73

Medical - Devices Industry

Max: 6.56
Q3: 3.52
Median: 2.22
Q1: 0.55
Min: 0.03

ABT’s Forward PEG Ratio of 1.73 is within the middle range of its peers in the Medical - Devices industry. This suggests a reasonable balance between the stock’s price and its expected growth, aligning with sector valuation norms.

NVDA

3.52

Semiconductors Industry

Max: 4.73
Q3: 2.80
Median: 1.11
Q1: 0.68
Min: 0.01

The Forward PEG Ratio is often not a primary valuation metric in the Semiconductors industry.

ABT vs. NVDA: A comparison of their Forward PEG Ratio against their respective Medical - Devices and Semiconductors industry benchmarks.

Price-to-Sales Ratio

ABT

5.52

Medical - Devices Industry

Max: 15.74
Q3: 8.12
Median: 3.40
Q1: 2.37
Min: 0.42

ABT’s P/S Ratio of 5.52 aligns with the market consensus for the Medical - Devices industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

NVDA

26.18

Semiconductors Industry

Max: 21.96
Q3: 10.21
Median: 4.45
Q1: 2.32
Min: 0.48

With a P/S Ratio of 26.18, NVDA trades at a valuation that eclipses even the highest in the Semiconductors industry. This implies the market has priced in exceptionally optimistic scenarios for future revenue growth, posing considerable valuation risk.

ABT vs. NVDA: A comparison of their P/S Ratio against their respective Medical - Devices and Semiconductors industry benchmarks.

Price-to-Book Ratio

ABT

4.81

Medical - Devices Industry

Max: 16.65
Q3: 8.03
Median: 3.73
Q1: 1.92
Min: 0.65

ABT’s P/B Ratio of 4.81 is within the conventional range for the Medical - Devices industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.

NVDA

46.45

Semiconductors Industry

Max: 13.12
Q3: 6.49
Median: 3.31
Q1: 1.74
Min: 0.23

At 46.45, NVDA’s P/B Ratio is at an extreme premium to the Semiconductors industry. This signifies that the market’s valuation is heavily reliant on future potential rather than its current net asset value, which can be a high-risk proposition.

ABT vs. NVDA: A comparison of their P/B Ratio against their respective Medical - Devices and Semiconductors industry benchmarks.

Valuation at a Glance

Symbol	ABT	NVDA
Price-to-Earnings Ratio (P/E, TTM)	17.40	50.73
Forward PEG Ratio (TTM)	1.73	3.52
Price-to-Sales Ratio (P/S, TTM)	5.52	26.18
Price-to-Book Ratio (P/B, TTM)	4.81	46.45
Price-to-Free Cash Flow Ratio (P/FCF, TTM)	35.14	53.95
EV-to-EBITDA (TTM)	21.49	42.68
EV-to-Sales (TTM)	5.68	26.15